Search the library

Plain words work. Use the arrow keys to move, Enter to open, Esc to close.

Menu

Paper·2022·Research article

The Soluble Folate Receptor in Autism Spectrum Disorder: Relation to Autism Severity and Leucovorin Treatment.

Frye RE, Lane A, Worner A, Werner BA, McCarty PJ, Scheck AC, Collins HL, Adelman SJ, Quadros EV, Rossignol DA

Journal of Personalized Medicine, 2022

In brief

Describes a second blood marker, the soluble folate receptor, and how it relates to autism severity and to leucovorin treatment.

A plain-language summary is not written yet

The foundation is writing summaries of its papers, starting with the most important ones. Until then, the citation and the link to the journal are below.

Citation

Frye RE, Lane A, Worner A, Werner BA, McCarty PJ, Scheck AC, Collins HL, Adelman SJ, Quadros EV, Rossignol DA. The Soluble Folate Receptor in Autism Spectrum Disorder: Relation to Autism Severity and Leucovorin Treatment. J Pers Med. 2022 Dec 8;12(12):2033. doi: 10.3390/jpm12122033. PMID: 36556254; PMCID: PMC9786140.

More on biomarkers

All papers on biomarkers

ADTF Weekly

One email a week. The research, explained.

A short video from Dr. Frye on one new paper, what it means for families, and what the foundation is working on. Free, and you can leave at any time.